Skip to main content
Erschienen in: Abdominal Radiology 12/2016

07.10.2016

Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer

verfasst von: Charis Bourgioti, Konstantinos Chatoupis, Chara Tzavara, Aristeidis Antoniou, Alexandros Rodolakis, Lia Angela Moulopoulos

Erschienen in: Abdominal Radiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Aim

To investigate the predictive ability of tumor size for deep myometrial invasion (≥50%) and metastatic lymphadenopathy, on maximal tumor diameter (MRI) of endometrial cancer.

Materials and methods

Our study population consisted of 105 patients (mean age: 59.8 years) with histologically confirmed endometrial cancer. All patients underwent preoperative pelvic MRI. Tumor maximal diameter (size) was calculated on multiple sequences, and the largest value was recorded. Logistic regression analysis was performed to investigate the association of maximal tumor diameter (MRI) with the depth of myometrial invasion and the presence of pelvic nodal metastases (histology); optimal tumor size cut-off for the prediction of deep myometrial involvement and nodal metastases was calculated using ROC analysis. Surgicopathological specimen examination was the standard of reference.

Results

Tumor size on MRI, independently predicted deep myometrial invasion. Optimal maximal tumor diameter cut-off for the prediction of deep myometrial invasion was 2 cm (SE 90%, SP 50.9%). When tumor size was used as a categorical variable in the multiple logistic regression model, tumor size >2 cm had 10.04 times greater odds of deep myometrial invasion (95% CI 3.34–30.17, p < 0.001). Optimal tumor size cut-off for prediction of nodal metastases was 4 cm (SE 60%, SP 76.9%). Multiple logistic regression analysis with nodal metastases as a dependent variable showed that tumor size >4 cm had 4.79 times greater odds for malignant dissemination to the lymph nodes (95% CI 1.00–23.09, p = 0.047).

Conclusion

Maximal tumor diameter on preoperative MRI may be yet another prognosticator for deep myometrial invasion and metastatic lymphadenopathy in patients with endometrial carcinoma.
Literatur
1.
Zurück zum Zitat Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy vs. laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12:130–136CrossRefPubMed Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy vs. laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12:130–136CrossRefPubMed
2.
Zurück zum Zitat Nougaret S, Reinhold C, Alsharif SS, et al. (2015) Endometrial cancer: combined MR volumetry and diffusion-weighted Imaging for assessment of myometrial and lymphovascular invasion and tumor grade. Radiology 276:797–808CrossRefPubMed Nougaret S, Reinhold C, Alsharif SS, et al. (2015) Endometrial cancer: combined MR volumetry and diffusion-weighted Imaging for assessment of myometrial and lymphovascular invasion and tumor grade. Radiology 276:797–808CrossRefPubMed
3.
Zurück zum Zitat Eriksson AGZ, Ducie J, Ali N, et al. (2016) Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol 140:394–399CrossRef Eriksson AGZ, Ducie J, Ali N, et al. (2016) Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol 140:394–399CrossRef
4.
Zurück zum Zitat Chi DS, Barakat RR, Palayekar MJ, et al. (2008) The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18:269–273CrossRefPubMed Chi DS, Barakat RR, Palayekar MJ, et al. (2008) The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18:269–273CrossRefPubMed
5.
Zurück zum Zitat Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al. (2012) Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127:5–10CrossRefPubMed Dowdy SC, Borah BJ, Bakkum-Gamez JN, et al. (2012) Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127:5–10CrossRefPubMed
6.
Zurück zum Zitat Karolewski K, Michalak A, Kojs Z, Jakubowicz J, Urbański K (2006) Classical prognostic factors in patients with non-advanced endometrial cancer treated with postoperative radiotherapy. Rep Pract Oncol Radiother 11:169–174CrossRef Karolewski K, Michalak A, Kojs Z, Jakubowicz J, Urbański K (2006) Classical prognostic factors in patients with non-advanced endometrial cancer treated with postoperative radiotherapy. Rep Pract Oncol Radiother 11:169–174CrossRef
7.
Zurück zum Zitat Giede C, Le T, Power P, SOGC-GOC-SCC Policy and Practice Guideline Committee, et al. (2013) The role of surgery in endometrial cancer. J Obstet Gynaecol Can 35:370–374CrossRefPubMed Giede C, Le T, Power P, SOGC-GOC-SCC Policy and Practice Guideline Committee, et al. (2013) The role of surgery in endometrial cancer. J Obstet Gynaecol Can 35:370–374CrossRefPubMed
8.
Zurück zum Zitat Kupets R, Le T, Le T, SOGC-GOC-SCC Policy and Practice Guidelines Committee, et al. (2013) The role of adjuvant therapy in endometrial cancer. J Obstet Gynaecol Can 35:375–379CrossRefPubMed Kupets R, Le T, Le T, SOGC-GOC-SCC Policy and Practice Guidelines Committee, et al. (2013) The role of adjuvant therapy in endometrial cancer. J Obstet Gynaecol Can 35:375–379CrossRefPubMed
9.
Zurück zum Zitat Ali A, Black D, Soslow RA (2007) Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 26:115–123CrossRefPubMed Ali A, Black D, Soslow RA (2007) Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 26:115–123CrossRefPubMed
10.
Zurück zum Zitat Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266:717–740CrossRefPubMed Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266:717–740CrossRefPubMed
11.
Zurück zum Zitat Freeman SJ, Aly AM, Kataoka MY, et al. (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 32:1805–1827CrossRefPubMed Freeman SJ, Aly AM, Kataoka MY, et al. (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 32:1805–1827CrossRefPubMed
12.
Zurück zum Zitat Kinkel K (2006) Pitfalls in staging uterine neoplasm with imaging: a review. Abdom Imaging 31:164–173CrossRefPubMed Kinkel K (2006) Pitfalls in staging uterine neoplasm with imaging: a review. Abdom Imaging 31:164–173CrossRefPubMed
13.
Zurück zum Zitat Todo Y, Choi HJ, Kang S, et al. (2013) Clinical significance of tumor volume in endometrial cancer: a Japan–Korea cooperative study. Gynecol Oncol 131:294–298CrossRefPubMed Todo Y, Choi HJ, Kang S, et al. (2013) Clinical significance of tumor volume in endometrial cancer: a Japan–Korea cooperative study. Gynecol Oncol 131:294–298CrossRefPubMed
14.
Zurück zum Zitat Ytre-Hauge S, Husby JA, Magnussen IJ, et al. (2015) Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. Int J Gynecol Cancer 25:459–466CrossRefPubMedPubMedCentral Ytre-Hauge S, Husby JA, Magnussen IJ, et al. (2015) Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. Int J Gynecol Cancer 25:459–466CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Mahdi H, Munkarah AR, Ali-Fehmi R, et al. (2015) Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer. Arch Gynecol Obstet 292:183–190CrossRefPubMed Mahdi H, Munkarah AR, Ali-Fehmi R, et al. (2015) Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer. Arch Gynecol Obstet 292:183–190CrossRefPubMed
16.
Zurück zum Zitat Shah C, Johnson EB, Everett E, et al. (2005) Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol 99:564–570CrossRefPubMed Shah C, Johnson EB, Everett E, et al. (2005) Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol 99:564–570CrossRefPubMed
17.
Zurück zum Zitat Senol T, Polat M, Ozkaya E, Karateke A (2015) Tumor diameter for prediction of recurrence, disease free and overall survival in endometrial cancer cases. Asian Pac J Cancer Prev 16:7463–7466CrossRefPubMed Senol T, Polat M, Ozkaya E, Karateke A (2015) Tumor diameter for prediction of recurrence, disease free and overall survival in endometrial cancer cases. Asian Pac J Cancer Prev 16:7463–7466CrossRefPubMed
18.
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN, et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035–2041CrossRefPubMed Creasman WT, Morrow CP, Bundy BN, et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035–2041CrossRefPubMed
19.
Zurück zum Zitat Gusberg SB, Jones HC Jr, Tovell HM (1960) Selection of treatment for corpus cancer. Am J Obstet Gynecol 80:374–380CrossRefPubMed Gusberg SB, Jones HC Jr, Tovell HM (1960) Selection of treatment for corpus cancer. Am J Obstet Gynecol 80:374–380CrossRefPubMed
20.
Zurück zum Zitat Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109CrossRefPubMed Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109CrossRefPubMed
21.
Zurück zum Zitat Soliman PT, Frumovitz M, Spannuth W, et al. (2010) Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol 119:291–294CrossRefPubMedPubMedCentral Soliman PT, Frumovitz M, Spannuth W, et al. (2010) Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol 119:291–294CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R (2013) Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer. Int J Gynecol Cancer 23:690–697CrossRefPubMed Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R (2013) Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer. Int J Gynecol Cancer 23:690–697CrossRefPubMed
23.
Zurück zum Zitat Mariani A, Dowdy SC, Cliby WA, et al. (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18CrossRefPubMedPubMedCentral Mariani A, Dowdy SC, Cliby WA, et al. (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Canlorbe G, Bendifallah S, Laas E, et al. (2016) Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: results of a French Multicenter Study. Ann Surg Oncol 23:171–177CrossRefPubMed Canlorbe G, Bendifallah S, Laas E, et al. (2016) Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: results of a French Multicenter Study. Ann Surg Oncol 23:171–177CrossRefPubMed
25.
Zurück zum Zitat AlHilli MM, Podratz KC, Dowdy SC, et al. (2013) Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 128:294–299CrossRefPubMed AlHilli MM, Podratz KC, Dowdy SC, et al. (2013) Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 128:294–299CrossRefPubMed
26.
Zurück zum Zitat Vargas R, Rauh-Hain JA, Clemmer J, et al. (2014) Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 133:216–220CrossRefPubMed Vargas R, Rauh-Hain JA, Clemmer J, et al. (2014) Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol 133:216–220CrossRefPubMed
27.
Zurück zum Zitat Kinkel K, Forstner R, Danza FM, European Society of Urogenital Imaging, et al. (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574CrossRefPubMed Kinkel K, Forstner R, Danza FM, European Society of Urogenital Imaging, et al. (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574CrossRefPubMed
Metadaten
Titel
Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer
verfasst von
Charis Bourgioti
Konstantinos Chatoupis
Chara Tzavara
Aristeidis Antoniou
Alexandros Rodolakis
Lia Angela Moulopoulos
Publikationsdatum
07.10.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 12/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0927-0

Weitere Artikel der Ausgabe 12/2016

Abdominal Radiology 12/2016 Zur Ausgabe

Classics in Abdominal Imaging

Popcorn ball calcification

Classics in Abdominal Imaging

The T2 shading sign

Classics in Abdominal Imaging

The tubal ring and ring of fire signs

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.